• SENSEX 74,442.21
    -339.55 (--0.45%)
  • BANKNIFTY 56,606.55
    134.60 (+0.24%)
  • HDFC Bank
    730.30 1,020.35(%)
  • Solar Industries
    19,273.75 11,641.10(%)
  • Raymond
    1,121.80 1,024.00(%)
  • Zensar Tech.
    479.80 868.50(%)
  • Infosys
    1,097.40 1,727.85(%)
  • Tata Inv.Corpn.
    750.30 1,184.00(%)
  • ESDS Software
    1,802.15 1,716.35(%)
  • Reliance Industries
    1,248.50 1,250.55(%)
  • TCS
    2,322.50 3,336.70(%)
  • Pine Labs
    191.50 134.75(%)
  • Hero Motocorp
    5,325.55 6,390.00(%)
  • Gland Pharma
    2,867.95 1,575.00(%)
  • Netweb Technol.
    4,654.00 2,820.80(%)
  • SBI
    978.00 816.25(%)
  • JSW Holdings
    10,990.00 10,500.05(%)
  • Bharat Electron
    387.65 380.35(%)
  • Cummins India
    4,930.00 3,802.55(%)
  • Coforge
    1,776.00 1,008.50(%)
  • HCL Technologies
    1,290.10 1,770.00(%)
  • Afcons Infrastr.
    304.70 479.05(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Biofil Chemicals & Pharmaceuticals Ltd Trading

  • Systematix
  • BSE Code : 3284.0
  • ISIN : INE829A01014
34.51 -2 (-6.20%)
  • As on 15 Sep 2026 (EOD)

  • Today’s Low

    32.36

  • Today’s High

    37.80

  • Open

    37.80

  • Perv Close

    36.79

  • 52W Low

    25.60

  • 52W High

    46.34

Key Indicators

  • P/E(TTM)

    114.93

  • Mar.Cap (₹Cr.)

    56.15

  • Div & Yield %

    0.00

  • Book Value(₹)

    13.25

  • Debt-Equity Ratio

    -6.20

  • AGM Date

    11-Sep-2026

  • EPS

    0.30

  • P/E Ratio

    114.93

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    56.15

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    16.27

  • BV (₹)

    13.30

  • Sales( ₹ in Cr.)

    28.40

  • NP (in Cr.)

    -0.57

  • NP Var(%)

    -203.0

  • Div%

    0.0

  • CPS (₹)

    -0.20

  • EPS (₹)

    -0.40

  • Traded Value (₹ in Lakhs)

    56.10

  • 52 Week High

    46.34

  • 52 Week Low

    25.60

  • Price BSE

    34.0

  • Price NSE

    35.00

  • Market Capital( in Cr.)

    56.10

  • P/C Ratio

    -183.70

  • P/E Ratio

    -96.50

  • Price Vs.BV

    -0.40

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 28.40 33.40 40.04 30.04 22.38 35.75
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 28.40 33.40 40.04 30.04 22.38 35.75
Other Income 3.08 0.31 0.49 0.10 0.15 0.80
Stock Adjustments 0.19 0.79 0.27 0.20 -3.59 2.77
Total Income 31.67 34.50 40.80 30.34 18.94 39.32
EXPENDITURE :            
Raw Materials 26.15 31.64 37.78 27.62 15.87 35.20
Power and Fuel Cost 0.22 0.28 0.38 0.33 0.30 0.29
Employee Cost 0.63 0.61 0.50 0.45 0.79 0.75
Other Manufacturing Expenses 0.16 0.17 0.17 0.05 0.09 0.23
Selling and Administration Expenses 0.64 0.57 0.56 0.54 0.37 0.37
Miscellaneous Expenses 0.15 0.08 0.11 0.08 0.05 0.08
Employee Benefit Expenses 0.63 0.61 0.50 0.45 0.79 0.75
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 27.94 33.35 39.49 29.06 17.46 36.92
Operating Profit 3.73 1.16 1.30 1.26 1.48 2.40
Interest 0.01 0.04 0.04 0.04 0.04 0.07
Gross Profit 3.72 1.12 1.26 1.22 1.44 2.33
Depreciation 0.27 0.38 0.40 0.43 0.43 0.41
Profit Before Tax 3.45 0.74 0.86 0.79 1.01 1.92
Current Tax 0.40 0.21 0.24 0.22 0.28 0.32
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.26 -0.03 -0.09 0.01 0.04 0.35
Reported Net Profit 2.79 0.56 0.71 0.56 0.70 1.24
Extraordinary Items 3.36 0.00 0.00 0.00 0.00 0.00
Adjusted Net Profit -0.57 0.56 0.71 0.56 0.70 1.24
Adjustment below Net Profit 0.00 0.00 0.19 -0.10 0.04 0.00
P & L Balance brought forward -31.27 -31.83 -32.60 -33.06 -33.79 -35.01
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -28.48 -31.27 -31.69 -32.60 -33.06 -33.77
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 1.71 0.34 0.44 0.34 0.43 0.76
Earnings Per Share(Adj)-Unit Curr 1.71 0.34 0.44 0.34 0.43 0.76
Book Value 13.25 11.54 11.19 10.63 10.35 9.91
Book Value(Adj)-Unit Curr 13.25 11.54 11.19 10.63 10.35 9.91

Shareholding Pattern

  • Promoter Group

    46.79%

  • Public Share Holding

    53.21%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 4,314,200 26.51 4,314,200 3
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 3,300,560 20.28 3,300,560 12
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 7,614,760 46.79 7,614,760 15
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 6,200 0.04 0 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 7,000 0.04 0 3
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 13,200 0.08 0 4
2] Non Institution
Bodies Corporate 1,905,765 11.71 1,807,565 69
Clearing Members 45,116 0.28 45,116 16
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 65,800 0.40 0 1
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 214,593 1.32 131,893 287
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 117,246 0.72 117,246 154
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 595,532 3.66 595,532 11
Individuals holding nominal share capital up to Rs. 1 lakh 5,691,447 34.97 5,107,647 24,437
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 100 0.00 0 1
Others 0 0.00 0 0
Sub Total 8,645,840 53.13 7,815,240 24,980
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 16,273,800 100.00 15,430,000 24,999

Company Background

Biofil Chemicals & Pharmaceuticals LtdTrading

  • Biofil Chemicals & Pharmaceuticals Ltd
  • BSE Code : 3284.0
  • ISIN : INE829A01014

  • Incorporation Year

    1985

  • Registered Office

    11/12 Sector E Sanwer Road
    Sanwer Road Industrial Area, Indore,
    Madhya Pradesh-452015

  • Telephone

    91-731-2426700

  • FAX

    91-731-2420926

  • Chairman

    Ketan Shah

  • Managing Director

  • Company Secretary

    Apoorv Jain

  • Auditor

    Maheshwari & Gupta

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    Ankit Consultancy Pvt Ltd
    Plot No. 60,
    Electronic Complex,Pardeshipura
    Mumbai - Indore - 452010

Biofil Chemicals & Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Biofil Chemicals 34.48 31.48 28.40 114.93 1.26
Abbott India 25,586.10 7,217.19 6,929.05 33.67 43.78
Astrazeneca Phar 6,785.35 2,304.07 2,275.58 100.01 27.86
Glaxosmi. Pharma 2,837.20 3,932.76 3,790.20 45.32 58.17
Novartis India 2,393.15 393.10 354.33 60.43 15.94
Cipla 1,365.00 20,102.60 18,979.95 35.87 13.88
Bliss GVS Pharma 722.45 773.53 729.81 67.14 12.51
Amrutanjan Healt 490.35 520.13 502.55 26.26 24.16
Fermenta Biotec. 475.05 474.15 450.25 22.18 18.77
Guj. Themis Bio. 423.35 168.25 165.82 113.20 18.05
Ambalal Sarabhai 40.61 19.52 3.94 75.20 6.77